Image (290c7038 Fd8c 4250 8569 99793e8864ea 01)
Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 43598-355
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 43598-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (290c7038 Fd8c 4250 8569 99793e8864ea 02)
Impact of other drugs on Lurasidone Pharmacokinetics(PK). Interacting drug: Ketoconazole 400mg/day CYP3A4 inhibitor. Moderate CYP2D6 inhibitor:
Not available. (The text appears incomplete and unclear to provide a useful description)*
Image (290c7038 Fd8c 4250 8569 99793e8864ea 03)
Figure 3: Impact Of Other Patient Factors On Lurasidone Hydrochloride Pharmacokinetics (290c7038 Fd8c 4250 8569 99793e8864ea 04)
Container120mg (Container120mg)
This is a package label containing information about its batch number, expiry date, serialization, and GTIN to be printed. The label shows an unvarnished area for imprinting the required information. It also has a long string of codes, symbols, and text arranged in rows and columns, which are not understandable and might be machine-readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
